Back to leadership

Kristian Humer, M.B.A

Kristian Humer joined Foghorn Therapeutics as Chief Financial Officer in April of 2024, with many years expertise and experience from the life science industry as well as Wall Street.

Kristian joined Foghorn from Viridian Therapeutics where he was the Chief Financial and Chief Business Officer. Prior to Viridian Therapeutics, Kristian was Managing Director in the healthcare investment banking group at Citi, where he helped lead the biopharma coverage effort. Kristian had a broad coverage universe across biotechnology and pharmaceutical industries globally, and was instrumental in advising clients on strategic matters, including equity, equity linked and M&A transactions. Prior to Citi, Kristian worked at Lehman Brothers, UBS and Merrill Lynch.

Kristian holds an MBA degree from Duke University’s Fuqua School of Business and a BA (Hons) degree in Accounting & Economics from the University of Reading. Kristian is also a member of the board of Sensei Biotherapeutics, a public biotechnology company.